Multivariate analyses demonstrated that LLGL2low/SLC7A5low was an independent favorable prognostic factor for DFS as well as lymph node negativity and ERα positivity in all analyzed breast cancer patients (Supplementary Table S7). Here, ESR1 is linked to breast carcinoma.